Innova Captab Limited (NSE:INNOVACAP)

India · Delayed Price · Currency is INR

680.75

+0.85 (0.13%)

Mar 9, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Drugs and Pharmaceutical Products	12.44B	10.81B	9.26B	8.01B	4.11B
Drugs and Pharmaceutical Products Growth	15.02%	16.72%	15.72%	94.94%	10.00%
Total	12.44B	10.81B	9.26B	8.01B	4.11B
Total Growth	15.02%	16.72%	15.72%	94.94%	10.00%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	9.15B	8.32B	8.45B	7.23B	3.70B
India Growth	9.96%	-1.47%	16.84%	95.52%	8.17%
outside India	3.19B	2.45B	806.63M	767.81M	397.91M
outside India Growth	30.49%	203.29%	5.06%	92.96%	30.89%
Total	12.34B	10.77B	9.25B	8.00B	4.10B
Total Growth	14.62%	16.38%	15.71%	95.27%	10.02%

Source: S&P Global Market Intelligence.